MoneyWorks4Me

A fair growth of 8.69% in the revenue at Rs. 14371.40 millions was reported in the December 2023 quarter as compared to Rs. 13221.90 millions during year-ago period.A good growth in profit of 25.99% reported to Rs. 3109.80  millions over Rs. 2468.30 millions of corresponding previous quarter.The company reported a good operating profit of 4433.00 millions compared to 3564.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 14371.40 13221.90 8.69 44102.80 40056.40 10.10 53487.30 49133.20 8.86
Other Income 556.10 442.30 25.73 1671.20 1045.20 59.89 1541.50 831.60 85.37
PBIDT 4433.00 3564.30 24.37 12906.90 10300.20 25.31 13597.80 11649.30 16.73
Interest 31.70 37.90 -16.36 96.40 119.80 -19.53 159.90 191.00 -16.28
PBDT 4401.30 3526.40 24.81 12810.50 10180.40 25.83 13437.90 11458.30 17.28
Depreciation 179.70 178.10 0.90 529.80 526.30 0.67 699.70 661.00 5.85
PBT 4221.60 3348.30 26.08 12280.70 9654.10 27.21 12738.20 10797.30 17.98
TAX 1111.80 880.00 26.34 3139.10 2474.20 26.87 3244.10 2810.30 15.44
Deferred Tax -21.60 -16.80 28.57 -57.20 -47.30 20.93 -11.90 -1.30 815.38
PAT 3109.80 2468.30 25.99 9141.60 7179.90 27.32 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 30.85 26.96 14.42 29.27 25.71 13.81 25.42 23.71 7.22
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..